Dupixent (dupilumab) - Sanofi, Regeneron
Dupilumab Utilization Among Pediatric Patients With Atopic Dermatitis: A National Epic Cosmos Database Analysis (ACAAI 2026) - Oct 28, 2026 - Abstract #R386; Pres time: Nov 14, 2026; 12:45 PM - 01:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 25; No abstract available 
Clinical • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Pediatrics
https://annualmeeting.acaai.org/2026/submit_abstract.cfm
 
Oct 28, 2026
 
Prev Next